Based on our cell cycle profiling results, our identification of a SIRT2-CDK2 interaction at early time points of infection, and increased CDK2 K6 acetylation following SIRT2 inhibition (Fig. 3G), we therefore focused our follow-up investigations on CDK2. This evidence concerns the gene CDK2 and infection.